Announcements

1. “A Multi-Agent Deep Reinforcement Learning Approach for Enhancement of COVID-19 CT Image Segmentation”
by Hanane Allioui, Mazin Abed Mohammed, Narjes Benameur, Belal Al-Khateeb, Karrar Hameed Abdulkareem, Begonya Garcia-Zapirain, Robertas Damaševičius and Rytis Maskeliūnas
J. Pers. Med. 2022, 12(2), 309; https://doi.org/10.3390/jpm12020309
Available online: https://www.mdpi.com/2075-4426/12/2/309

2. “Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions”
by Gabriele Savioli, Iride Francesca Ceresa, Nicole Gri, Gaia Bavestrello Piccini, Yaroslava Longhitano, Christian Zanza, Andrea Piccioni, Ciro Esposito, Giovanni Ricevuti and Maria Antonietta Bressan
J. Pers. Med. 2022, 12(2), 279; https://doi.org/10.3390/jpm12020279
Available online: https://www.mdpi.com/2075-4426/12/2/279

3. “Artificial Intelligence-Driven Prediction Modeling and Decision Making in Spine Surgery Using Hybrid Machine Learning Models”
by Babak Saravi, Frank Hassel, Sara Ülkümen, Alisia Zink, Veronika Shavlokhova, Sebastien Couillard-Despres, Martin Boeker, Peter Obid and Gernot Michael Lang
J. Pers. Med. 2022, 12(4), 509; https://doi.org/10.3390/jpm12040509
Available online: https://www.mdpi.com/2075-4426/12/4/509

4. “Correlation between Peri-Implant Marginal Bone Loss Progression and Peri-Implant Sulcular Fluid Levels of Metalloproteinase-8”
by Renzo Guarnieri, Alessio Zanza, Maurilio D’Angelo, Dario Di Nardo, Andrea Del Giudice, Alessandro Mazzoni, Rodolfo Reda and Luca Testarelli
J. Pers. Med. 2022, 12(1), 58; https://doi.org/10.3390/jpm12010058
Available online: https://www.mdpi.com/2075-4426/12/1/58

5. “Usefulness of Magnetic Mallet in Oral Surgery and Implantology: A Systematic Review”
by Francesco Bennardo, Selene Barone, Camillo Vocaturo, Ludovica Nucci, Alessandro Antonelli and Amerigo Giudice
J. Pers. Med. 2022, 12(1), 108; https://doi.org/10.3390/jpm12010108
Available online: https://www.mdpi.com/2075-4426/12/1/108

6. “Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems”
by Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari et al.
J. Pers. Med. 2022, 12(7), 1073; https://doi.org/10.3390/jpm12071073
Available online: https://www.mdpi.com/2075-4426/12/7/1073

7. “COVID-19 Detection in CT/X-ray Imagery Using Vision Transformers”
by Mohamad Mahmoud Al Rahhal, Yakoub Bazi, Rami M. Jomaa, Ahmad AlShibli, Naif Alajlan, Mohamed Lamine Mekhalfi and Farid Melgani
J. Pers. Med. 2022, 12(2), 310; https://doi.org/10.3390/jpm12020310
Available online: https://www.mdpi.com/2075-4426/12/2/310

8. “Emerging Biomarkers for Early Detection of Chronic Kidney Disease”
by Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir and Joško Božić
J. Pers. Med. 2022, 12(4), 548; https://doi.org/10.3390/jpm12040548
Available online: https://www.mdpi.com/2075-4426/12/4/548

9. “LungNet22: A Fine-Tuned Model for Multiclass Classification and Prediction of Lung Disease Using X-ray Images”
by F. M. Javed Mehedi Shamrat, Sami Azam, Asif Karim, Rakibul Islam, Zarrin Tasnim, Pronab Ghosh and Friso De Boer
J. Pers. Med. 2022, 12(5), 680; https://doi.org/10.3390/jpm12050680
Available online: https://www.mdpi.com/2075-4426/12/5/680

10. “Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self”
by Michael Maes
J. Pers. Med. 2022, 12(3), 403; https://doi.org/10.3390/jpm12030403
Available online: https://www.mdpi.com/2075-4426/12/3/403

11. “Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe”
by Denis Horgan, Giuseppe Curigliano, Olaf Rieß, Paul Hofman, Reinhard Büttner, Pierfranco Conte, Tanja Cufer, William M. Gallagher, Nadia Georges, Keith Kerr et al.
J. Pers. Med. 2022, 12(1), 72; https://doi.org/10.3390/jpm12010072
Available online: https://www.mdpi.com/2075-4426/12/1/72

12. “Relationship between Epicardial and Coronary Adipose Tissue and the Expression of Adiponectin, Leptin, and Interleukin 6 in Patients with Coronary Artery Disease”
by Olga V. Gruzdeva, Yulia A. Dyleva, Ekaterina V. Belik, Maxim Y. Sinitsky, Aleksandr N. Stasev, Aleksandr N. Kokov, Natalia K. Brel, Evgenia O. Krivkina, Evgenia E. Bychkova, Roman S. Tarasov et al.
J. Pers. Med. 2022, 12(2), 129; https://doi.org/10.3390/jpm12020129
Available online: https://www.mdpi.com/2075-4426/12/2/129

13. “Endotypes of Prematurity and Phenotypes of Bronchopulmonary Dysplasia: Toward Personalized Neonatology”
by Maria Pierro, Karen Van Mechelen, Elke van Westering-Kroon, Eduardo Villamor-Martínez and Eduardo Villamor
J. Pers. Med. 2022, 12(5), 687; https://doi.org/10.3390/jpm12050687
Available online: https://www.mdpi.com/2075-4426/12/5/687

14. “Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents?”
by Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner and Ulf D. Kahlert
J. Pers. Med. 2022, 12(3), 478; https://doi.org/10.3390/jpm12030478
Available online: https://www.mdpi.com/2075-4426/12/3/478

15. “Dendrimers, an Emerging Opportunity in Personalized Medicine?”
by Anne-Marie Caminade
J. Pers. Med. 2022, 12(8), 1334; https://doi.org/10.3390/jpm12081334
Available online: https://www.mdpi.com/2075-4426/12/8/1334

16. “Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care”
by Elpiniki Rentzeperi, Stavroula Pegiou, Theocharis Koufakis, Maria Grammatiki and Kalliopi Kotsa
J. Pers. Med. 2022, 12(3), 454; https://doi.org/10.3390/jpm12030454
Available online: https://www.mdpi.com/2075-4426/12/3/454

17. “Should Neurosurgeons Try to Preserve Non-Traditional Brain Networks? A Systematic Review of the Neuroscientific Evidence”
by Nicholas B. Dadario and Michael E. Sughrue
J. Pers. Med. 2022, 12(4), 587; https://doi.org/10.3390/jpm12040587
Available online: https://www.mdpi.com/2075-4426/12/4/587

18. “Identification of Early Esophageal Cancer by Semantic Segmentation”
by Yu-Jen Fang, Arvind Mukundan, Yu-Ming Tsao, Chien-Wei Huang and Hsiang-Chen Wang
J. Pers. Med. 2022, 12(8), 1204; https://doi.org/10.3390/jpm12081204
Available online: https://www.mdpi.com/2075-4426/12/8/1204

19. “Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms”
by Chiara Villa, Eleonora Rivellini, Marialuisa Lavitrano and Romina Combi
J. Pers. Med. 2022, 12(1), 29; https://doi.org/10.3390/jpm12010029
Available online: https://www.mdpi.com/2075-4426/12/1/29

20. “Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease”
by Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama and Nobuko Matsushima
J. Pers. Med. 2022, 12(3), 444; https://doi.org/10.3390/jpm12030444
Available online: https://www.mdpi.com/2075-4426/12/3/444

We are glad to announce the new Impact Factor of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is 3.4. This information is available in JCR Help Data, which includes the total number of citations, the JIF and the 5-year JIF, and can be found using the following link: https://jcr.help.clarivate.com/Content/data-updates.htm.

As for the official update of the Impact Factor, Clarivate stated that the journal profile and full set of data will be included in the JCR data reload in October of this year.

As of 28 June 2023, new journal impact factors (IFs) were released. However, we were informed by Clarivate^TM that for some journals, Journal of Personalized Medicine (JPM, ISSN: 2075-4426) included, there has been a delay. Unfortunately, this is the reason that the new IF is not present on the journal webpage, nor can it be found on JCR. With that in mind, we would like to inform you that the new IF for JPM will be announced in the next few weeks. Please note that the journal is listed in the official JCR 2022 journal list available for download here.

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal topics (selected)
	Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue	growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
	Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue	DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
	Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue	lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
	Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue	multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
	Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue	Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

Coronary physiological assessment is a rapidly developing field in cardiology. Precise invasive or less-invasive (image based) physiological evaluation can provide reliable support for the tailored treatment of coronary macro- and microvascular coronary diseases and consequently have an important impact on the efficacy and safety of therapy.

In our webinar, we summarize the current scientific results concerning the advances of specific coronary microvascular indices determined via both invasive and less invasive methods. The relevance of clinical implications and therapeutical options will be discussed as well, including specific patient populations, e.g., ACS, CCS, (M)INOCA and COVID-19 cases.

Date: 12 July 2023 at 10:00 a.m. CEST
Webinar ID: 898 6464 8512

Register now for free!

Program:

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.

Webinar Chairs and Keynote Speakers:

• Dr. Gábor Tamás Szabó, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary and Center for Biomedical Research and Translational Surgery, Medical University Vienna, Vienna, Austria;
• Dr. Zsolt Kőszegi, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary and Szabolcs – Szatmár – Bereg County Hospitals and University Teaching Hospital, Nyíregyháza, Hungary;
• Dr. Zsolt Piróth, Gottsegen National Cardiovascular Center, 29 Haller Str., Budapest, Hungary;
• Dr. Yongzhen Fan, Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, China.

Relevant Special Issue:
“Applied Invasive Coronary Physiology for Tailored Treatment of Coronary Artery Disease”
Guest Editors: Dr. Gábor Tamás Szabó and Dr. Zsolt Kőszegi

MDPI will be attending the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control (JSIPC), which will be held from 20 to 22 July 2023, in Yokohama, Japan.

JSIPC was founded in 1986 as the Japanese Society for Environmental Infection (JSEI). The first annual meeting was attended by about 230 participants. Over the last 30 years, the number of annual meeting participants has notably increased to over 7,000, with the membership total exceeding 9,500. JSIPC was founded to address not only the primary issue of nosocomial infection, but all other infectious diseases caused by environmental changes. The theme of the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control is “Professionalism”. The conference will cover various topics related to infection prevention and control, such as occupational safety and health, oral health, environmental health, infectious disease, antibiotic administration, vaccination, antibiotic resistance and misuse, and health education.

The following MDPI journals will be represented:

• Antibiotics;
• Vaccines;
• Infectious Disease Reports;
• Journal of Personalized Medicine (JPM);
• Tropical Medicine and Infectious Disease (TropicalMed).

If you plan on attending this conference, please feel free to stop by our booth (#B21) and have a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: http://jsipc38.umin.jp/.

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2023)

We are pleased to inform you that the Journal of Personalized Medicine’s 2022 CiteScore is 2.6. JPM’s CiteScore ranks 153 among 309 titles (Q2) in the “Medicine (miscellaneous)” category, continuing to build momentum in its field. We would like to extend our congratulations to all concerned.

For more journal statistics, please visit https://www.mdpi.com/journal/jpm/stats. 

Conference: 60th European Renal Association (ERA) Congress

Date: 15–17 June 2023

Location: Milan, Italy

MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.

The following MDPI journals will be represented:

• JCM;
• JPM;
• Kidney and Dialysis;
• Diagnostics;
• Clinics and Practice;
• Uro;
• Cells;
• BioChem;
• Transplantology.